Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03092323
Title A Randomized Trial of Pembrolizumab & Radiotherapy Versus Radiotherapy in High-Risk Soft Tissue Sarcoma of the Extremity (SU2C-SARC032)
Acronym SU2C-SARC032
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Sarcoma Alliance for Research through Collaboration
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | ITA | CAN | AUS

Facility Status City State Zip Country Details
University of California Los Angeles Los Angeles California 90095 United States Details
Mayo Clinic- Florida Jacksonville Florida 32224 United States Details
University of Iowa Hospitals & Clinics Iowa City Iowa 52242 United States Details
University of Kansas Medical Center Kansas City Kansas 66160 United States Details
Johns Hopkins University Baltimore Maryland 21231 United States Details
Massachusetts General Hospital Cancer Center Boston Massachusetts 02114 United States Details
Dana-Farber Cancer Institute Boston Massachusetts 02215 United States Details
University of Michigan Ann Arbor Michigan 48109 United States Details
Washington University Saint Louis Missouri 63110 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
Duke University Durham North Carolina 27705 United States Details
The Ohio State University Columbus Ohio 43210 United States Details
Oregon Health & Science University Portland Oregon 97239 United States Details
University of Pennsylvania- Abramson Cancer Center Philadelphia Pennsylvania 19106 United States Details
University of Pittsburgh (UPMC Hillman Cancer Center) Pittsburgh Pennsylvania 15232 United States Details
Chris O'Brien Hospital Camperdown New South Wales 2050 Australia Details
Princess Alexandra Hospital Brisbane Queensland 4102 Australia Details
Peter MacCallum Cancer Centre Melbourne Victoria 3000 Australia Details
McGill University Health Centre Montreal Quebec H4A 3J1 Canada Details
Fondazione IRCCS Istituto Nazionale dei Tumori Milano MI 20133 Italy Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field